Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OBIO | Common Stock | Award | $0 | +869K | +17.39% | $0.00 | 5.87M | Apr 13, 2023 | Held by Covidien Group S.a.r.l. | F1 |
Id | Content |
---|---|
F1 | Represents shares acquired by a subsidiary of the reporting person, which shares were issued as an earnout under the Agreement and Plan of Merger (the "Merger Agreement") dated effective as of July 4, 2022, by and among Orchestra BioMed Holdings, Inc., Health Sciences Acquisitions Corporation 2 ("HSAC2") and HSAC Olympus Merger Sub, Inc. (as amended, the "Merger Agreement"). |